Galmed Pharmaceuticals Announces Commencement of Patient Screening for the ARREST Study in Europe, and Reports Third Quarter 2015 Financial Results
Go back to Galmed Pharmaceuticals Announces Commencement of Patient Screening for the ARREST Study in Europe, and Reports Third Quarter 2015 Financial Results| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.61 -0.01 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $9.70 | |||
| Open | $0.59 | 52 Week Low | $2.78 | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.58 | EPS | $0.00 | |||
| Volume | 195,796 | |||||
